San Jose, CA (PRWEB) January 03, 2014
Follow us on LinkedIn – Single Cell Omics, a cutting edge technology, mainly integrates advanced technology with biology for a variety of single cell applications. Single Cell Omics, a strong diagnostic and clinical research tool, enables researchers in comprehending cellular variations during cell proliferation; investigating cycle-dependent effects in single cells; and detecting cellular subpopulations as well as differentiation states. Developments targeted at improving sensitivity and throughput of single cell omics technologies are additionally expected to benefit the market.
The trend report titled “Single Cell Omics” announced by Global Industry Analysts Inc., is a focused research paper which provides cursory insights into the technology, its evolution, applications, and future prospects. In addition to providing coverage on corporate initiatives of key companies worldwide, the report also offers global market estimates and projections for Single Cell Omics technology and products in US dollars for years 2012 through 2017. Key geographic market quantitatively analysed include the Unites States, Europe, Asia Pacific, and Japan. Also covered are companies such as BD Biosciences, BioNano Genomics Inc., DVS Sciences Inc., Fluidigm Corp., and Life Technologies Corp., among others.
For more details about this trend report, please visit http://www.strategyr.com/TrendReport.asp?code=146035.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/